Form 4 for STTK Shattuck Labs, Inc.
Accepted 2022-01-12 00:00:00 ET · period of report 2022-01-10 · accession 0000899243-22-001797 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-01-12 | 2022-01-10 | STTK | Pandite Arundathy N. | Chief Medical Off | A - Grant | $0.00 | +34.7K | 140.9K | +33% | $0 |
| D | 2022-01-12 | 2022-01-10 | STTK | Pandite Arundathy N. | Chief Medical Off | A - Grant | $0.00 | +69.5K | 69.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-10 | A | A | 34,738 | $0.00 | 140,904 | D | — | — | (F1) Consists of 34,738 restricted stock units, which will vest in four equal annual installments beginning on January 10, 2023, subject to the Reporting Person's continued service to the Issuer. |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-01-10 | A | A | 69,475 | $0.00 | 69,475 | D | $7.43 · — to 2032-01-10 | 69,475 Common Stock | (F2) This option represented a right to purchase a total of 69,475 shares of the Issuer's common stock, one quarter of which will vest on January 10, 2023, with the remaining three quarters vesting in equal monthly installments through January 10, 2026, subject to the Reporting Person's continued service to the Issuer. |